Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Pancreatic Neoplasms 1Gastrointestinal Stromal Tumors 1Gallbladder Neoplasms 1Fallopian Tube Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Bile Duct Neoplasms 1Appendiceal Neoplasms 1

Interventions

Radiotherapy 17Magnetic Resonance Spectroscopy 16Psychiatric Rehabilitation 13Cyclophosphamide 13Early Intervention, Educational 11Methotrexate 9Doxorubicin 9Counseling 9Biopsy 9Vincristine 8Cytarabine 7Carboplatin 7Specimen Handling 6Neoadjuvant Therapy 6Immunohistochemistry 6Gene Expression Profiling 6Dexamethasone 6Chemotherapy, Adjuvant 6Prednisolone 5Peripheral Blood Stem Cell Transplantation 5Leucovorin 5Immunoenzyme Techniques 5High-Energy Shock Waves 5Fluorouracil 5Filgrastim 5Colposcopy 5Cisplatin 5Busulfan 5X-Rays 4Polymerase Chain Reaction 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × NIH × motexafin lutetium × Clear all
NCT00087191 2013-01-16

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

National Cancer Institute (NCI)

Phase NA Terminated
30 enrolled
GastrointestinalGynecologicSarcomaThoracic

Carcinoma, Ovarian Epithelial, Appendiceal Neoplasms, Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Colonic Neoplasms, Fallopian Tube Neoplasms, Gallbladder Neoplasms, Carcinoma, Hepatocellular, Pancreatic Neoplasms, Rectal Neoplasms, Sarcoma, Stomach Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡